Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

Abstract Increased monocyte/macrophage (Mφ) apoptosis occurs in patients with systemic lupus erythematosus (SLE) and is mediated, at least in part, by an autoreactive CD4+ T cell subset. Furthermore, autoreactive murine CD4+ T cells that kill syngeneic Mφ in vitro induce a lupus-like disease in vivo. However, it is unclear whether increased Mφ apoptosis in SLE per se is sufficient to accelerate/promote autoimmunity. We have investigated whether increased Mφ apoptosis in vivo, induced by the administration of clodronate liposomes, can exacerbate the autoimmune phenotype in NZB × SWR (SNF1) lupus-prone mice, and induce autoantibody production in haplotype-matched BALB/c × DBA1 (DBF1) non-lupus-prone mice. Lupus-prone mice SNF1 mice that were treated with clodronate liposomes, but not mice treated with vehicle, developed significant increases in autoantibodies to dsDNA, nucleosomes, and the idiotypically related family of nephritic Abs IdLNF1, when compared with untreated SNF1 mice. Furthermore, clodronate treatment hastened the onset of proteinuria and worsened SNF1 lupus nephritis. When compared with vehicle-treated controls, clodronate-treated non-lupus-prone DBF1 mice developed significantly higher levels of anti-nucleosome and IdLNF1 Abs but did not develop lupus nephritis. We propose that Mφ apoptosis contributes to the pathogenesis of autoantibody formation and organ damage through both an increase in the apoptotic load and impairment in the clearance of apoptotic material. This study suggests that mechanisms that induce scavenger cell apoptosis, such as death induced by autoreactive cytotoxic T cells observed in SLE, could play a pathogenic role and contribute to the severity of the disease.

Bibliography

Denny, M. F., Chandaroy, P., Killen, P. D., Caricchio, R., Lewis, E. E., Richardson, B. C., Lee, K.-D., Gavalchin, J., & Kaplan, M. J. (2006). Accelerated Macrophage Apoptosis Induces Autoantibody Formation and Organ Damage in Systemic Lupus Erythematosus. The Journal of Immunology, 176(4), 2095–2104.

Authors 9 University of Pennsylvania
  1. Michael F. Denny (first)
  2. Parthapratim Chandaroy (additional)
  3. Paul D. Killen (additional)
  4. Roberto Caricchio (additional) University of Pennsylvania
  5. Emily E. Lewis (additional)
  6. Bruce C. Richardson (additional)
  7. Kyung-Dall Lee (additional)
  8. Jerrie Gavalchin (additional)
  9. Mariana J. Kaplan (additional)
References 88 Referenced 107
  1. Kaplan, M. J.. 2004. Apoptosis in systemic lupus erythematosus. Clin. Immunol. 112: 210-218. (10.1016/j.clim.2004.04.007)
  2. Amoura, Z., H. Chabre, S. Koutouzov, C. Lotton, A. Cabrespines, J. F. Bach, L. Jacob. 1994. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mplpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37: 1684-1688. (10.1002/art.1780371118)
  3. Kaplan, M. J., E. E. Lewis, E. A. Shelden, E. Somers, R. Pavlic, W. J. McCune, B. C. Richardson. 2002. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J. Immunol. 169: 6020-6029. (10.4049/jimmunol.169.10.6020)
  4. Ren, Y., J. Tang, M. Y. Mok, A. W. Chan, A. Wu, C. S. Lau. 2003. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 48: 2888-2897. (10.1002/art.11237)
  5. Richardson, B. C., J. R. Strahler, T. S. Pivirotto, J. Quddus, G. E. Bayliss, L. A. Gross, K. S. O’Rourke, D. Powers, S. M. Hanash, M. A. Johnson. 1992. Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum. 35: 647-662. (10.1002/art.1780350608)
  6. Bengtsson, A. A., G. Sturfelt, B. Gullstrand, L. Truedsson. 2004. Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus: an additional mechanism to increased autoantigen load?. Clin. Exp. Immunol. 135: 535-543. (10.1111/j.1365-2249.2003.02386.x)
  7. Fadok, V. A., G. Chimini. 2001. The phagocytosis of apoptotic cells. Semin. Immunol. 13: 365-372. (10.1006/smim.2001.0333)
  8. Jiang, N., C. F. Reich, III, D. S. Pisetsky. 2003. Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells. Blood 102: 2243-2250. (10.1182/blood-2002-10-3312)
  9. Van Rooijen, N., A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93. (10.1016/0022-1759(94)90012-4)
  10. Van Rooijen, N., E. van Kesteren-Hendrikx. 2002. Clodronate liposomes: perspectives in research and therapeutics. J. Liposome Res. 12: 81-94. (10.1081/LPR-120004780)
  11. Espenes, A., C. M. Press, N. Van Rooijen, T. Landsverk. 1997. Apoptosis in phagocytotic cells of lymphoid tissues in rainbow trout (Oncorhynchus mykiss) following administration of clodronate liposomes. Cell Tissue Res. 289: 323-331. (10.1007/s004410050879)
  12. Buiting, A. M., F. Zhou, J. A. Bakker, N. Van Rooijen, L. Huang. 1996. Biodistribution of clodronate and liposomes used in the liposome mediated macrophage “suicide” approach. J. Immunol. Methods 192: 55-62. (10.1016/0022-1759(96)00034-8)
  13. Cheng, H., T. M. Tumpey, H. F. Staats, N. Van Rooijen, J. E. Oakes, R. N. Lausch. 2000. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection. Invest. Ophtalmol. Vis. Sci. 41: 1402-1409.
  14. Ciavarra, R. P., K. Buhrer, N. Van Rooijen, B. Tedeschi. 1997. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells. J. Immunol. 158: 1749-1755. (10.4049/jimmunol.158.4.1749)
  15. Price, K., C. J. Knupp, A. H. Tatum, F. Jiang, M. Stoll, J. Gavalchin. 2002. Molecular identification of pathogenetic IdLNF+1 autoantibody idiotypes derived from the NZB × SWR F1 model for systemic lupus erythematosus. J. Autoimmun. 19: 87-101. (10.1006/jaut.2002.0612)
  16. Lee, K. D., S. Nir, D. Papahadjopoulos. 1993. Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes. Biochemistry 32: 889-899. (10.1021/bi00054a021)
  17. Lee, K. D., K. Hong, D. Papahadjopoulos. 1992. Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density. Biochim. Biophys. Acta 1103: 185-197. (10.1016/0005-2736(92)90086-2)
  18. Bartlett, G. R.. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234: 466-468. (10.1016/S0021-9258(18)70226-3)
  19. Kaplan, M. J., D. Ray, R. R. Mo, R. L. Yung, B. C. Richardson. 2000. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. J. Immunol. 15: 2897-2904. (10.4049/jimmunol.164.6.2897)
  20. Chung, C. S., G. Y. Song, J. Lomas, H. H. Simms, I. H. Chaudry, A. Ayala. 2003. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J. Leukocyte Biol. 74: 344-351. (10.1189/jlb.0102006)
  21. Yung, R., M. Kaplan, D. Ray, K. Schneider, R. R. Mo, K. Johnson, B. Richardson. 2001. Autoreactive murine Th1 and Th2 cells kill syngeneic macrophages and induce autoantibodies. Lupus 10: 539-546. (10.1191/096120301701549660)
  22. Gavalchin, J., R. A. Seder, S. K. Datta. 1987. The NZB × SWR model of lupus nephritis. I. Cross-reactive idiotypes of monoclonal anti-DNA antibodies in relation to antigenic specificity, charge, and allotype: identification of interconnected idiotype families inherited from the normal SWR and the autoimmune NZB parents. J. Immunol. 138: 128-137. (10.4049/jimmunol.138.1.128)
  23. Mohan, C., S. Adams, V. Stanik, S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177: 1367-1381. (10.1084/jem.177.5.1367)
  24. Cohen, P. L., R. Caricchio, V. Abraham, T. D. Camenisch, J. C. Jennette, R. A. Roubey, H. S. Earp, G. Matsushima, E. A. Reap. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196: 135-140. (10.1084/jem.20012094)
  25. Pehrson, J. R.. 1989. Thymine dimer formation as a probe of the path of DNA in and between nucleosomes in intact chromatin. Proc. Natl. Acad. Sci. USA 86: 9149-9153. (10.1073/pnas.86.23.9149)
  26. Seiler, P., P. Aichele, B. Odermatt, H. Hengartner, R. M. Zinkernagel, R. A. Schwendener. 1997. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 10: 2626-2633. (10.1002/eji.1830271023)
  27. Rozemuller, H., S. Knaan-Shanzer, A. Hagenbeek, L. van Bloois, G. Storm, A. C. Martens. 2004. Enhanced engraftment of human cells in RAG2/γc double-knockout mice after treatment with CL2MDP liposomes. Exp. Hematol. 32: 1118-1125. (10.1016/j.exphem.2004.08.002)
  28. Van Rooijen, N., R. van Nieuwmegen. 1984. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate: an enzyme-histochemical study. Cell Tissue Res. 238: 355-358. (10.1007/BF00217308)
  29. Buiting, A. M., Z. De Rover, N. Van Rooijen. 1995. Brucella abortus causes an accelerated repopulation of the spleen and liver of mice by macrophages after their liposome-mediated depletion. J. Med. Microbiol. 42: 133-140. (10.1099/00222615-42-2-133)
  30. Knupp, C. J., A. H. Uner, A. H. Tatum, J. Gavalchin. 1992. The onset of nephritis in the (NZB × SWR)F1 murine model for systemic lupus erythematosus correlates with an increase in the ratio of CD4 to CD8 T lymphocytes specific for the nephritogenic idiotype (IdLNF1). Clin. Immunol. Immunopathol. 65: 167-175. (10.1016/0090-1229(92)90220-I)
  31. Uner, A. H., A. H. Tatum, C. J. Knupp, J. Gavalchin. 1998. Characteristics of auto anti-idiotypic antibodies reactive with antibodies expressing the pathogenic idiotype, IdLNF1, in the (NZB × SWR)F1 model for lupus nephritis and its parental strains. J. Autoimmun. 11: 233-240. (10.1006/jaut.1998.0201)
  32. Kalled, S. L., A. H. Cutler, S. K. Datta, D. W. Thomas. 1998. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J. Immunol. 160: 2158-2165. (10.4049/jimmunol.160.5.2158)
  33. Aichele, P., J. Zinke, L. Grode, R. A. Schwendener, S. H. Kaufmann, P. Seiler. 2003. Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J. Immunol. 171: 1148-1155. (10.4049/jimmunol.171.3.1148)
  34. Alves-Rosa, F., C. Stanganelli, J. Cabrera, N. Van Rooijen, M. S. Palermo, M. A. Isturiz. 2000. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood 96: 2834-2840. (10.1182/blood.V96.8.2834.h8002834_2834_2840)
  35. Mevorach, D., J. L. Zhou, X. Song, K. B. Elkon. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188: 387-392. (10.1084/jem.188.2.387)
  36. Steinman, C. R.. 1984. Circulating DNA in systemic lupus erythematosus: isolation and characterization. J. Clin. Invest. 73: 832-841. (10.1172/JCI111278)
  37. Trebeden-Negre, H., B. Weill, C. Fournier, F. Batteux. 2003. B cell apoptosis accelerates the onset of murine lupus. Eur. J. Immunol. 33: 1603-1612. (10.1002/eji.200323665)
  38. Van Nieuwenhuijze, A. E., T. Van Lopik, R. J. Smeenk, L. A. Aarden. 2003. Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus. Ann. Rheum. Dis. 62: 10-14. (10.1136/ard.62.1.10)
  39. Casciola-Rosen, L. A., G. Anhalt, A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330. (10.1084/jem.179.4.1317)
  40. Richardson, B. C., R. L. Yung, K. J. Johnson, P. E. Rowse, N. D. Lalwani. 1996. Monocyte apoptosis in patients with active lupus. Arthritis Rheum. 39: 1432-1434. (10.1002/art.1780390827)
  41. Kalled, S. L., A. H. Cutler, L. C. Burkly. 2001. Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment. J. Immunol. 167: 1740-1747. (10.4049/jimmunol.167.3.1740)
  42. Shoshan, Y., I. Shapira, E. Toubi, I. Frolkis, M. Yaron, D. Mevorach. 2001. Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells. J. Immunol. 167: 5963-5969. (10.4049/jimmunol.167.10.5963)
  43. Hsieh, S. C., H. S. Yu, W. W. Lin, K. H. Sun, C. Y. Tsai, D. F. Huang, Y. Y. Tsai, C. L. Yu. 2003. Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 131: 506-516. (10.1046/j.1365-2249.2003.02084.x)
  44. Hanayama, R., M. Tanaka, K. Miyasaka, K. Aozasa, M. Koike, Y. Uchiyama, S. Nagata. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 1147-1150. (10.1126/science.1094359)
  45. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101: 890-898. (10.1172/JCI1112)
  46. Huynh, M. L., V. A. Fadok, P. M. Henson. 2002. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109: 41-50. (10.1172/JCI0211638)
  47. Kurosaka, K., N. Watanabe, Y. Kobayashi. 1998. Production of proinflammatory cytokines by phorbol myristate acetate-treated THP-1 cells and monocyte-derived macrophages after phagocytosis of apoptotic CTLL-2 cells. J. Immunol. 161: 6245-6249. (10.4049/jimmunol.161.11.6245)
  48. Rovere, P., M. G. Sabbadini, F. Fazzini, A. Bondanza, V. S. Zimmermann, C. Rugarli, A. A. Manfredi. 2000. Remnants of suicidal cells fostering systemic autoaggression: apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum. 43: 1663-1672. (10.1002/1529-0131(200008)43:8<1663::AID-ANR1>3.0.CO;2-1)
  49. Miwa, K., M. Asano, R. Horai, Y. Iwakura, S. Nagata, T. Suda. 1998. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand. Nat. Med. 4: 1287-1292. (10.1038/3276)
  50. Rovere, P., C. Vallinoto, A. Bondanza, M. C. Crosti, M. Rescigno, P. Ricciardi-Castagnoli, C. Rugarli, A. A. Manfredi. 1998. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 161: 4467-4471. (10.4049/jimmunol.161.9.4467)
  51. Chang, M. K., C. J. Binder, Y. I. Miller, G. Subbanagounder, G. J. Silverman, J. A. Berliner, J. L. Witztum. 2004. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200: 1359-1370. (10.1084/jem.20031763)
  52. Kramers, K., C. Stemmer, M. Monestier, M. C. van Bruggen, T. P. Rijke-Schilder, M. N. Hylkema, R. J. Smeenk, S. Muller, J. H. Berden. 1996. Specificity of monoclonal anti-nucleosome auto-antibodies derived from lupus mice. J. Autoimmun. 9: 723-729. (10.1006/jaut.1996.0094)
  53. Laderach, D., S. Koutouzov, J. F. Bach, A. M. Yamamoto. 2003. Concomitant early appearance of anti-ribonucleoprotein and anti-nucleosome antibodies in lupus prone mice. J. Autoimmun. 20: 161-170. (10.1016/S0896-8411(02)00114-2)
  54. Shi, Y., A. Kaliyaperumal, L. Lu, S. Southwood, A. Sette, M. A. Michaels, S. K. Datta. 1998. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor α chain. J. Exp. Med. 187: 367-378. (10.1084/jem.187.3.367)
  55. Yung, R. L., J. Quddus, C. E. Chrisp, K. J. Johnson, B. C. Richardson. 1995. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154: 3025-3035. (10.4049/jimmunol.154.6.3025)
  56. Kimura, M., E. Gleichmann. 1985. The Lyb-3+5+ subset of B cells is not required for lupus-like autoantibody formation caused by graft-vs-host reaction. J. Immunol. 135: 3845-3849. (10.4049/jimmunol.135.6.3845)
  57. Kaplan, M. J., Q. Lu, A. Wu, J. Attwood, B. Richardson. 2004. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 172: 3652-3661. (10.4049/jimmunol.172.6.3652)
  58. Casciola-Rosen, L., F. Andrade, D. Ulanet, W. B. Wong, A. Rosen. 1999. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 190: 815-826. (10.1084/jem.190.6.815)
  59. Yung, R. L., J. Quddus, C. E. Chrisp, K. J. Johnson, B. C. Richardson. 1995. Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol. 154: 3025-3035. (10.4049/jimmunol.154.6.3025)
  60. Yung, R., R. Williams, K. Johnson, C. Phillips, L. Stoolman, S. Chang, B. Richardson. 1997. Mechanisms of drug-induced lupus. III. Sex-specific differences in T cell homing may explain increased disease severity in female mice. Arthritis Rheum. 40: 1334-1343. (10.1002/art.1780400719)
  61. Quddus, J., K. J. Johnson, J. Gavalchin, E. P. Amento, C. E. Chrisp, R. L. Yung, B. C. Richardson. 1993. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92: 38-53. (10.1172/JCI116576)
  62. Catrina, A. I., C. Trollmo, E. af Klint, M. Engstrom, J. Lampa, Y. Hermansson, L. Klareskog, A. K. Ulfgren. 2005. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum. 52: 61-72. (10.1002/art.20764)
  63. D’Auria, F., P. Rovere-Querini, M. Giazzon, P. Ajello, E. Baldissera, A. A. Manfredi, M. G. Sabbadini. 2004. Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-α antibodies. J. Intern. Med. 255: 409-418. (10.1111/j.1365-2796.2003.01298.x)
  64. Gavalchin, J., J. A. Nicklas, J. W. Eastcott, M. P. Madaio, B. D. Stollar, R. S. Schwartz, S. K. Datta. 1985. Lupus-prone (SWR × NZB)F1 mice produce potentially nephritogenic autoantibodies inherited from the normal SWR parent. J. Immunol. 134: 885-894. (10.4049/jimmunol.134.2.885)
  65. Gavalchin, J., S. K. Datta. 1987. The NZB × SWR model of lupus nephritis. II. Autoantibodies deposited in renal lesions show a distinctive and restricted idiotypic diversity. J. Immunol. 138: 138-148. (10.4049/jimmunol.138.1.138)
  66. Amoura, Z., J. C. Piette, J. F. Bach, S. Koutouzov. 1999. The key role of nucleosomes in lupus. Arthritis Rheum. 42: 833-843. (10.1002/1529-0131(199905)42:5<833::AID-ANR1>3.0.CO;2-T)
  67. Hahn, B. H.. 1998. Antibodies to DNA. N. Engl. J. Med. 338: 1359-1368. (10.1056/NEJM199805073381906)
  68. Uner, A. H., C. J. Knupp, A. H. Tatum, J. Gavalchin. 1994. Treatment with antibody reactive with the nephritogenic idiotype, IdLNF1, suppresses its production and leads to prolonged survival of (NZB × SWR)F1 mice. J. Autoimmun. 7: 27-44. (10.1006/jaut.1994.1003)
  69. Vlahakos, D. V., M. H. Foster, S. Adams, M. Katz, A. A. Ucci, K. J. Barrett, S. K. Datta, M. P. Madaio. 1992. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 41: 1690-1700. (10.1038/ki.1992.242)
  70. Xie, C., Z. Liang, S. Chang, C. Mohan. 2003. Use of a novel elution regimen reveals the dominance of polyreactive antinuclear autoantibodies in lupus kidneys. Arthritis Rheum. 48: 2343-2352. (10.1002/art.11092)
  71. Baumann, I., W. Kolowos, R. E. Voll, B. Manger, U. Gaipl, W. L. Neuhuber, T. Kirchner, J. R. Kalden, M. Herrmann. 2002. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46: 191-201. (10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K)
  72. Albert, M. L., S. F. Pearce, L. M. Francisco, B. Sauter, P. Roy, R. L. Silverstein, N. Bhardwaj. 1998. Immature dendritic cells phagocytose apoptotic cells via v5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188: 1359-1368. (10.1084/jem.188.7.1359)
  73. Albert, M. L., B. Sauter, N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86-89. (10.1038/32183)
  74. Inaba, K., S. Turley, F. Yamaide, T. Iyoda, K. Mahnke, M. Inaba, P. Pack, M. Subklewe, B. Sauter, D. Sheff, et al 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188: 2163-2173. (10.1084/jem.188.11.2163)
  75. Kurts, C., J. F. Miller, R. M. Subramaniam, F. R. Carbone, W. R. Heath. 1998. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188: 409-414. (10.1084/jem.188.2.409)
  76. Rovere, P., F. Fazzini, M. G. Sabbadini, A. A. Manfredi. 2000. Apoptosis and systemic autoimmunity: the dendritic cell connection. Eur. J. Histochem. 44: 229-236.
  77. Bave, U., H. Vallin, G. V. Alm, L. Ronnblom. 2001. Activation of natural interferon-α producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines. J. Autoimmun. 171: 71-80. (10.1006/jaut.2001.0519)
  78. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294: 1540-1543. (10.1126/science.1064890)
  79. Jordan, M. B., N. Van Rooijen, S. Izui, J. Kappler, P. Marrack. 2003. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 101: 594-601. (10.1182/blood-2001-11-0061)
  80. Pennanen, N., S. Lapinjoki, A. Urtti, J. Monkkonen. 1995. Effect of liposomal and free bisphosphonates on the IL-1β, IL-6 and TNFα secretion from RAW 264 cells in vitro. Pharm. Res. 12: 916-922. (10.1023/A:1016281608773)
  81. Lucas, M., L. M. Stuart, J. Savill, A. Lacy-Hulbert. 2003. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J. Immunol. 171: 2610-2615. (10.4049/jimmunol.171.5.2610)
  82. De Albuquerque, D. A., V. Saxena, D. E. Adams, G. P. Boivin, H. I. Brunner, D. P. Witte, R. R. Singh. 2004. An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis. Kidney Int. 65: 846-859. (10.1111/j.1523-1755.2004.00462.x)
  83. Baatz, H., J. Puchta, R. Reszka, U. Pleyer. 2001. Macrophage depletion prevents leukocyte adhesion and disease induction in experimental melanin-protein induced uveitis. Exp. Eye Res. 73: 101-109. (10.1006/exer.2001.1016)
  84. Barrera, P., A. Blom, P. L. van Lent, L. van Bloois, J. H. Beijnen, N. Van Rooijen, M. C. de Waal Malefijt, L. B. Van de Putte, G. Storm, W. B. Van den Berg. 2000. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum. 43: 1951-1959. (10.1002/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K)
  85. Ceponis, A., E. Waris, J. Monkkonen, L. Laasonen, M. Hyttinen, S. A. Solovieva, R. Hanemaaijer, A. Bitsch, Y. T. Konttinen. 2001. Effects of low-dose, noncytotoxic, intraarticular liposomal clodronate on development of erosions and proteoglycan loss in established antigen-induced arthritis in rabbits. Arthritis Rheum. 44: 1908-1916. (10.1002/1529-0131(200108)44:8<1908::AID-ART329>3.0.CO;2-4)
  86. Van Rooijen, N., N. Kors, G. Kraal. 1989. Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J. Leukocyte Biol. 45: 97-104. (10.1002/jlb.45.2.97)
  87. Meuret, G., J. Bammert, G. Hoffmann. 1974. Kinetics of human monocytopoiesis. Blood 44: 801-816. (10.1182/blood.V44.6.801.801)
  88. Meuret, G., G. Hoffmann. 1973. Monocyte kinetic studies in normal and disease states. Br. J. Haematol. 24: 275-285. (10.1111/j.1365-2141.1973.tb01652.x)
Dates
Type When
Created 11 years, 4 months ago (April 20, 2014, 8:31 p.m.)
Deposited 7 months, 4 weeks ago (Jan. 2, 2025, 12:22 p.m.)
Indexed 2 months, 1 week ago (June 17, 2025, 6:50 a.m.)
Issued 19 years, 6 months ago (Feb. 15, 2006)
Published 19 years, 6 months ago (Feb. 15, 2006)
Published Print 19 years, 6 months ago (Feb. 15, 2006)
Funders 0

None

@article{Denny_2006, title={Accelerated Macrophage Apoptosis Induces Autoantibody Formation and Organ Damage in Systemic Lupus Erythematosus}, volume={176}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.176.4.2095}, DOI={10.4049/jimmunol.176.4.2095}, number={4}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Denny, Michael F. and Chandaroy, Parthapratim and Killen, Paul D. and Caricchio, Roberto and Lewis, Emily E. and Richardson, Bruce C. and Lee, Kyung-Dall and Gavalchin, Jerrie and Kaplan, Mariana J.}, year={2006}, month=feb, pages={2095–2104} }